Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 22(12)2021 Jun 08.
Article in English | MEDLINE | ID: mdl-34201404

ABSTRACT

Neurodegenerative-neuroinflammatory disorders of the retina seriously hamper human vision. In searching for key factors that contribute to the development of these pathologies, we considered potential interactions among purinergic neuromodulation, glycinergic neurotransmission, and microglia activity in the retina. Energy deprivation at cellular levels is mainly due to impaired blood circulation leading to increased release of ATP and adenosine as well as glutamate and glycine. Interactions between these modulators and neurotransmitters are manifold. First, P2Y purinoceptor agonists facilitate reuptake of glycine by glycine transporter 1, while its inhibitors reduce reverse-mode operation; these events may lower extracellular glycine levels. The consequential changes in extracellular glycine concentration can lead to parallel changes in the activity of NR1/NR2B type NMDA receptors of which glycine is a mandatory agonist, and thereby may reduce neurodegenerative events in the retina. Second, P2Y purinoceptor agonists and glycine transporter 1 inhibitors may indirectly inhibit microglia activity by decreasing neuronal or glial glycine release in energy-compromised retina. These inhibitions may have a role in microglia activation, which is present during development and progression of neurodegenerative disorders such as glaucomatous and diabetic retinopathies and age-related macular degeneration or loss of retinal neurons caused by thromboembolic events. We have hypothesized that glycine transporter 1 inhibitors and P2Y purinoceptor agonists may have therapeutic importance in neurodegenerative-neuroinflammatory disorders of the retina by decreasing NR1/NR2B NMDA receptor activity and production and release of a series of proinflammatory cytokines from microglial cells.


Subject(s)
Glycine Agents/metabolism , Inflammation/pathology , Neurodegenerative Diseases/pathology , Neurons/pathology , Receptors, Purinergic/metabolism , Retinal Diseases/pathology , Animals , Humans , Inflammation/complications , Inflammation/metabolism , Neurodegenerative Diseases/complications , Neurodegenerative Diseases/metabolism , Neurons/metabolism , Retinal Diseases/complications , Retinal Diseases/metabolism
2.
Commun Biol ; 2: 401, 2019.
Article in English | MEDLINE | ID: mdl-31701029

ABSTRACT

Voltage-gated potassium (Kv) channel dysfunction causes a variety of inherited disorders, but developing small molecules that activate Kv channels has proven challenging. We recently discovered that the inhibitory neurotransmitter γ-aminobutyric acid (GABA) directly activates Kv channels KCNQ3 and KCNQ5. Here, finding that inhibitory neurotransmitter glycine does not activate KCNQs, we re-engineered it in silico to introduce predicted KCNQ-opening properties, screened by in silico docking, then validated the hits in vitro. Attaching a fluorophenyl ring to glycine optimized its electrostatic potential, converting it to a low-nM affinity KCNQ channel activator. Repositioning the phenyl ring fluorine and/or adding a methylsulfonyl group increased the efficacy of the re-engineered glycines and switched their target KCNQs. Combining KCNQ2- and KCNQ3-specific glycine derivatives synergistically potentiated KCNQ2/3 activation by exploiting heteromeric channel composition. Thus, in silico optimization and docking, combined with functional screening of only three compounds, facilitated re-engineering of glycine to develop several potent KCNQ activators.


Subject(s)
KCNQ Potassium Channels/chemistry , KCNQ Potassium Channels/metabolism , Animals , Computer Simulation , Glycine/analogs & derivatives , Glycine/chemistry , Glycine/metabolism , Glycine Agents/chemistry , Glycine Agents/metabolism , KCNQ Potassium Channels/genetics , KCNQ2 Potassium Channel/chemistry , KCNQ2 Potassium Channel/genetics , KCNQ2 Potassium Channel/metabolism , KCNQ3 Potassium Channel/chemistry , KCNQ3 Potassium Channel/genetics , KCNQ3 Potassium Channel/metabolism , Models, Molecular , Molecular Docking Simulation , Protein Engineering/methods , Receptors, Glycine/antagonists & inhibitors , Static Electricity , Synthetic Biology , Xenopus Proteins/chemistry , Xenopus Proteins/genetics , Xenopus Proteins/metabolism , Xenopus laevis/genetics , Xenopus laevis/metabolism
3.
Chemistry ; 25(59): 13523-13530, 2019 Oct 22.
Article in English | MEDLINE | ID: mdl-31283853

ABSTRACT

Self-assembling peptides that are capable of adopting ß-sheet structures can generate nanofibers that lead to hydrogel formation. Herein, to tune the supramolecular morphologies, mechanical properties, and stimuli responses of the hydrogels, we investigated glycine substitution in a ß-sheet-forming amphiphilic peptide. Glycine substitution generally enhances conformational flexibility. Indeed, glycine substitution in an amphiphilic peptide weakened the hydrogels or even inhibited the gelation. However, unexpectedly, glycine substitution at the center of the peptide molecule significantly enhanced the hydrogel stiffness. The central glycine substitution affected the molecular packing and led to twisted ß-sheet structures and to nanofiber bundling, which likely led to the stiffened hydrogel. Importantly, the supramolecular structures were accurately predicted by molecular dynamics simulations, demonstrating the helpfulness of these techniques for the identification of self-assembling peptides. The hydrogel formed by the amphiphilic peptide with the central glycine substitution had cell adhesive function, and showed a reversible thermal gel-to-sol transition. Thus, glycine substitution is effective in modulating self-assembling structures, rheological properties, and dynamics of biofunctional self-assembling peptides.


Subject(s)
Adhesives/chemistry , Glycine Agents/metabolism , Glycine/chemistry , Peptides/chemistry , Glycine Agents/chemistry , Hydrogels/chemistry , Molecular Dynamics Simulation , Nanofibers/chemistry , Rheology
4.
Biomed Khim ; 60(4): 403-15, 2014.
Article in Russian | MEDLINE | ID: mdl-25249524

ABSTRACT

The literature data on glycine metabolism in neural tissue, mitochondrial Gly-cleaving system, Gly-catching system in neural and glial cells are summarized. The peculiarities of localization and distribution of specific glycine receptors and binding-sites in nervous tissue of mammals are described. Four types of glycine-binding receptors are described: own specific glycine receptor (Gly-R), ionotropic receptor, which binds N-methyl-D-aspartate selectively (NMDA-R), and ionotropic receptors of g-aminobutyrate (GABA A -R, GABA С -R). The features of glycine effects in neuroglial cultures are discussed.


Subject(s)
Glycine/metabolism , Neuroglia/physiology , Neurons/physiology , Receptors, Glycine/metabolism , Animals , Gene Expression Regulation , Glutamic Acid/metabolism , Glycine Agents/metabolism , Glycine Agents/pharmacology , Humans , N-Methylaspartate/metabolism , Neuroglia/cytology , Neuroglia/drug effects , Neurons/cytology , Neurons/drug effects , Receptors, GABA/genetics , Receptors, GABA/metabolism , Receptors, Glycine/chemistry , Receptors, Glycine/genetics , Receptors, N-Methyl-D-Aspartate/genetics , Receptors, N-Methyl-D-Aspartate/metabolism , gamma-Aminobutyric Acid/metabolism
5.
PLoS One ; 9(2): e88560, 2014.
Article in English | MEDLINE | ID: mdl-24586343

ABSTRACT

This paper examines the role of inhibition in generating the receptive-field properties of local edge detector (LED) ganglion cells in the rabbit retina. We confirm that the feed-forward inhibition is largely glycinergic but, contrary to a recent report, our data demonstrate that the glycinergic inhibition contributes to temporal tuning for the OFF and ON inputs to the LEDs by delaying the onset of spiking; this delay was more pronounced for the ON inputs (∼ 340 ms) than the OFF inputs (∼ 12 ms). Blocking glycinergic transmission reduced the delay to spike onset and increased the responses to flickering stimuli at high frequencies. Analysis of the synaptic conductances indicates that glycinergic amacrine cells affect temporal tuning through both postsynaptic inhibition of the LEDs and presynaptic modulation of the bipolar cells that drive the LEDs. The results also confirm that presynaptic GABAergic transmission contributes significantly to the concentric surround antagonism in LEDs; however, unlike presumed LEDs in the mouse retina, the surround is only partly generated by spiking amacrine cells.


Subject(s)
Glycine Agents/metabolism , Retina/physiology , Retinal Ganglion Cells/physiology , Synaptic Transmission/physiology , Action Potentials/physiology , Amacrine Cells/metabolism , Animals , Glycine Agents/antagonists & inhibitors , Rabbits , Retinal Ganglion Cells/drug effects , Strychnine/pharmacology , Tetrodotoxin/pharmacology
6.
Pain ; 154(11): 2452-2462, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23886522

ABSTRACT

The present study examined the antinociceptive effects of gelsemine, the principal alkaloid in Gelsemium sempervirens Ait. A single intrathecal injection of gelsemine produced potent and specific antinociception in formalin-induced tonic pain, bone cancer-induced mechanical allodynia, and spinal nerve ligation-induced painful neuropathy. The antinociception was dose-dependent, with maximal inhibition of 50% to 60% and ED50 values of 0.5 to 0.6 µg. Multiple daily intrathecal injections of gelsemine for 7 days induced no tolerance to antinociception in the rat model of bone cancer pain. Spinal gelsemine was not effective in altering contralateral paw withdrawal thresholds, and had only a slight inhibitory effect on formalin-induced acute nociception. The specific antinociception of gelsemine in chronic pain was blocked dose-dependently by the glycine receptor (GlyR) antagonist strychnine with an apparent ID50 value of 3.8 µg. Gelsemine concentration-dependently displaced H(3)-strychnine binding to the membrane fraction of rat spinal cord homogenates, with a 100% displacement and a Ki of 21.9µM. Gene ablation of the GlyR α3 subunit (α3 GlyR) but not α1 GlyR, by a 7-day intrathecal injection of small interfering RNA (siRNA) targeting α3 GlyR or α1 GlyR, nearly completely prevented gelsemine-induced antinociception in neuropathic pain. Our results demonstrate that gelsemine produces potent and specific antinociception in chronic pain states without induction of apparent tolerance. The results also suggest that gelsemine produces antinociception by activation of spinal α3 glycine receptors, and support the notion that spinal α3 glycine receptors are a potential therapeutic target molecule for the management of chronic pain.


Subject(s)
Alkaloids/pharmacology , Analgesics , Chronic Pain/drug therapy , Gelsemium/chemistry , Receptors, Glycine/drug effects , Spinal Cord/drug effects , Animals , Binding, Competitive/drug effects , Bone Neoplasms/complications , Chronic Pain/etiology , Glycine Agents/metabolism , Glycine Agents/pharmacology , Injections, Intraventricular , Injections, Spinal , Ligation , Male , Neuralgia/drug therapy , Pain Measurement , Postural Balance/drug effects , RNA, Small Interfering/genetics , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Receptors, Glycine/metabolism , Spinal Nerves/injuries , Strychnine/metabolism , Strychnine/pharmacology
7.
Eur J Neurosci ; 28(1): 128-36, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18616561

ABSTRACT

Adenosine trisphosphate (ATP) activates purinoceptors and acts as a neurotransmitter in the nervous system. In the retina, we previously reported that the immunohistochemical distribution of the subset of P2-purinoceptors differs between the ON and OFF pathways. Here, we investigated whether ATP activates P2-purinoceptors and modulates the physiological function of the mouse retina. We also examined if signal processing by P2-purinoceptors is pathway specific. Results showed that ATP activated both ON- and OFF-cholinergic amacrine cells. However, responses in OFF-cholinergic amacrine cells were greater than those in ON-cholinergic amacrine cells. Pharmacological studies in OFF-cholinergic amacrine cells showed that the response of OFF-cholinergic amacrine cells is mediated P2X(2)-purinoceptors. Further, ATP increased gamma-aminobutyric acid (GABA)ergic inhibitory postsynaptic currents (IPSCs) in OFF- but not ON-cholinergic amacrine cells. The increase in GABAergic IPSCs was mediated by P2-purinoceptors. P2-purinoceptor-mediated signals suppressed OFF ganglion cells but activated ON ganglion cells. Our findings indicate that ATP physiologically modulates signal processing of the ON and OFF pathways in a pathway-specific manner through P2-purinoceptors.


Subject(s)
Receptors, Purinergic P2/metabolism , Retina/metabolism , Signal Transduction/physiology , Action Potentials/physiology , Adenosine Triphosphate/metabolism , Animals , GABA Antagonists/metabolism , Glycine Agents/metabolism , Inhibitory Postsynaptic Potentials/physiology , Mice , Mice, Transgenic , Pyridazines/metabolism , Pyridoxal Phosphate/analogs & derivatives , Pyridoxal Phosphate/metabolism , Receptors, Purinergic P2/genetics , Retina/cytology , Strychnine/metabolism , gamma-Aminobutyric Acid/metabolism
8.
Eur J Neurosci ; 24(4): 1117-23, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16930437

ABSTRACT

Melanopsin-containing retinal ganglion cells (RGCs) project to the suprachiasmatic nuclei (SCN) and mediate photoentrainment of the circadian system. Melanopsin is a novel retinal-based photopigment that renders these cells intrinsically photosensitive (ip). Although genetic ablation of melanopsin abolishes the intrinsic light response, it has a surprisingly minor effect on circadian photoentrainment. This and other non-visual responses to light are lost only when the melanopsin deficiency is coupled with mutations that disable classical rod and cone photoreceptors, suggesting that melanopsin-containing RGCs also receive rod- and cone-driven synaptic inputs. Using whole-cell patch-clamp recording, we demonstrate that light triggers synaptic currents in ipRGCs via activation of ionotropic glutamate and gamma-aminobutyric acid (GABA) receptors. Miniature postsynaptic currents (mPSCs) were clearly observed in ipRGCs, although they were less robust and were seen less frequently than those seen in non-ip cells. Pharmacological treatments revealed that the majority of ipRGCs receive excitatory glutamatergic inputs that were blocked by DNQX and/or kynurenic acid, as well as inhibitory GABAergic inputs that were blocked by bicuculline. Other ipRGCs received either glutamatergic or GABAergic inputs nearly exclusively. Although strychnine (Strych)-sensitive mPSCs were evident on many non-ipRGCs, indicating the presence of glycinergic inputs, we saw no evidence of Strych-sensitive events in ipRGCs. Based on these results, it is clear that SCN-projecting RGCs can respond to light both via an intrinsic melanopsin-based signaling cascade and via a synaptic pathway driven by classical rod and/or cone photoreceptors. It remains to be determined how the ipRGCs integrate these temporally distinct inputs to generate the signals that mediate circadian photoentrainment and other non-visual responses to light.


Subject(s)
Biological Clocks/physiology , Circadian Rhythm/physiology , Neural Pathways , Retinal Ganglion Cells/metabolism , Synapses/metabolism , Animals , Bicuculline/metabolism , Excitatory Amino Acid Antagonists/metabolism , GABA Antagonists/metabolism , Glycine Agents/metabolism , Kynurenic Acid/metabolism , Light , Neural Pathways/metabolism , Neural Pathways/physiology , Patch-Clamp Techniques , Quinoxalines/metabolism , Rats , Rats, Sprague-Dawley , Receptors, GABA/metabolism , Receptors, Glutamate/metabolism , Retinal Ganglion Cells/cytology , Rod Opsins/metabolism , Strychnine/metabolism , Synaptic Transmission/physiology , Tetrodotoxin/metabolism
9.
Eur J Neurosci ; 23(12): 3225-9, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16820013

ABSTRACT

The mesolimbic dopamine (DA) system, projecting from the ventral tegmental area (VTA) to the nucleus accumbens (nAcc), is involved in reward-related behaviours and addictive processes, such as alcoholism and drug addiction. It was recently suggested that strychnine-sensitive glycine receptors (GlyR) in the nAcc regulate both basal and ethanol-induced mesolimbic DA activity via a neuronal loop involving endogenous activation of nicotinic acetylcholine receptors (nAChR) in the VTA. However, as the nAcc appears to contain few glycine-immunoreactive cell bodies or fibres, the question as to what may be the endogenous ligand for GlyRs in this brain region remains open. Here we have investigated whether the amino acid taurine could serve this purpose using in vivo microdialysis in awake, freely moving male Wistar rats. Local perfusion of taurine (1, 10 or 100 mm in the perfusate) increased DA levels in the nAcc. The taurine (10 mm)-induced DA increase was, similarly to that previously observed after ethanol, completely blocked by (i) perfusion of the competitive GlyR antagonist strychnine in the nAcc, (ii) perfusion of the nAChR antagonist mecamylamine (100 microm) in the VTA, and (iii) systemic administration of the acetylcholine-depleting drug vesamicol (0.4 mg/kg, i.p). The present results suggest that taurine may be an endogenous ligand for GlyRs in the nAcc and that the taurine-induced elevation of DA levels in this area, similarly to that observed after local ethanol, is mediated via a neuronal loop involving endogenous activation of nAChRs in the VTA.


Subject(s)
Dopamine/metabolism , Glycine Agents/metabolism , Nucleus Accumbens/metabolism , Strychnine/metabolism , Taurine/metabolism , Animals , Ganglionic Blockers/metabolism , Male , Mecamylamine , Microdialysis , Neuromuscular Depolarizing Agents/metabolism , Nucleus Accumbens/anatomy & histology , Piperidines/metabolism , Rats , Rats, Wistar , Receptors, Glycine/antagonists & inhibitors , Receptors, Glycine/metabolism
10.
J Physiol ; 571(Pt 2): 403-13, 2006 Mar 01.
Article in English | MEDLINE | ID: mdl-16410279

ABSTRACT

Activation of spinal muscarinic acetylcholine receptors (mAChRs) inhibits nociception. However, the cellular mechanisms of this action are not fully known. In this study, we determined the role of mAChR subtypes in regulation of synaptic glycine release in the spinal cord. Whole-cell voltage-clamp recordings were performed on lamina II neurones in the rat spinal cord slices. The mAChR agonist oxotremorine-M significantly increased the frequency of glycinergic sIPSCs but not mIPSCs. Surprisingly, the effect of oxotremorine-M on sIPSCs was largely attenuated at a higher concentration. On the other hand, 1-10 microm oxotremorine-M dose-dependently increased the frequency of sIPSCs in rats pretreated with intrathecal pertussis toxin. Furthermore, oxotremorine-M also dose-dependently increased the frequency of sIPSCs in the presence of himbacine (an M2/M4 mAChR antagonist) or AF-DX116 (an M2 mAChR antagonist). The M3 mAChR antagonist 4-DAMP abolished the stimulatory effect of oxotremorine-M on sIPSCs. Interestingly, the GABA(B) receptor antagonist CGP55845 potentiated the stimulatory effect of oxotremorine-M on sIPSCs. In the presence of CGP55845, both himbacine and AF-DX116 similarly reduced the potentiating effect of oxotremorine-M on sIPSCs. Collectively, these data suggest that the M3 subtype is present on the somatodendritic site of glycinergic neurones and is mainly responsible for muscarinic potentiation of glycinergic input to spinal dorsal horn neurones. Concurrent stimulation of mAChRs on adjacent GABAergic interneurones attenuates synaptic glycine release through presynaptic GABA(B) receptors on glycinergic interneurones. This study illustrates a complex dynamic interaction between GABAergic and glycinergic synapses in the spinal cord dorsal horn.


Subject(s)
Glycine Agents/metabolism , Nociceptors/physiology , Receptors, Muscarinic/physiology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Animals , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Glycine/metabolism , Glycine Plasma Membrane Transport Proteins/physiology , Male , Models, Biological , Muscarinic Agonists/pharmacology , Neurons , Nociceptors/drug effects , Oxotremorine/pharmacology , Posterior Horn Cells/physiology , Rats , Rats, Sprague-Dawley , Receptor, Muscarinic M2/physiology , Receptor, Muscarinic M4/physiology , Receptors, GABA-B/physiology , Spinal Cord/physiology
11.
Brain Res Bull ; 67(6): 492-7, 2005 Nov 30.
Article in English | MEDLINE | ID: mdl-16216698

ABSTRACT

Effects of glycine on ON type rod-dominant bipolar cells (RBCs) were studied in isolated, superfused carp retina by intracellular recording technique and in carp retinal slice preparation by whole cell recording. Glycine of 4mM hyperpolarized RBCs and potentiated their light responses to large light spots, which was reversed by co-application of 10 microM strychnine. It was further found that illumination of the receptive field surround did not affect the depolarizing center response of RBCs. The above result therefore suggests that glycine modulates the center response of RBCs. Focal application of glycine to either dendrites or axon terminals of RBCs failed to induce any currents in both isolated cell and retinal slice preparations. On the other hand, glycine of 4mM increased the amplitude of the scotopic electroretinographic PIII component, which reflects the activity of rod photoreceptors. It seems likely that modulation by glycine of the RBC center response may be in part ascribed to a consequence of the potentiation of rod responses by glycine.


Subject(s)
Carps/physiology , Glycine Agents/metabolism , Glycine/metabolism , Retinal Bipolar Cells/physiology , Retinal Rod Photoreceptor Cells/physiology , Animals , Electroretinography , Membrane Potentials/drug effects , Organ Culture Techniques , Photic Stimulation , Retinal Bipolar Cells/drug effects , Retinal Rod Photoreceptor Cells/drug effects , Strychnine/pharmacology
12.
J Pharmacol Exp Ther ; 300(2): 526-34, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11805213

ABSTRACT

Glycine receptors (GlyRs) are pentameric ligand-gated ion channels that inhibit neurotransmission in the adult brainstem and spinal cord. GlyR function is potentiated by ethanol in vitro, and a mutant GlyR subunit alpha(1)(S267Q) is insensitive to the potentiating effects of ethanol. To test the importance of GlyR for the actions of ethanol in vivo, we constructed transgenic mice with this mutation. Under the control of synapsin I regulatory sequences, transgenic expression of S267Q mutant GlyR alpha(1) subunits in the nervous system was demonstrated using [(3)H]strychnine binding and immunoblotting. These mice showed decreased sensitivity to ethanol in three behavioral tests: ethanol inhibition of strychnine seizures, motor incoordination (rotarod), and loss of righting reflex. There was no change in ethanol sensitivity in tests of acute functional tolerance or body temperature, and there was no change in ethanol metabolism. Transgene effects were pharmacologically specific for ethanol, compared with pentobarbital, flurazepam, and ketamine. These results support the idea that glycine receptors contribute to some behavioral actions of ethanol and that ethanol sensitivity can be changed in vivo by transgenic expression of a single receptor subunit.


Subject(s)
Behavior, Animal/drug effects , Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Mutation/genetics , Receptors, Glycine/biosynthesis , Receptors, Glycine/genetics , Animals , Body Temperature/drug effects , Central Nervous System Depressants/pharmacokinetics , DNA Primers , Ethanol/pharmacokinetics , Glycine/pharmacology , Glycine Agents/metabolism , Immunoblotting , Maze Learning/drug effects , Mice , Mice, Transgenic , Motor Activity/drug effects , Oocytes/drug effects , Patch-Clamp Techniques , Phenotype , Postural Balance/drug effects , Seizures/genetics , Spinal Cord/drug effects , Spinal Cord/physiology , Strychnine/metabolism , Xenopus
13.
J Org Chem ; 66(10): 3474-83, 2001 May 18.
Article in English | MEDLINE | ID: mdl-11348132

ABSTRACT

The practical synthesis of a series of tricyclic indole-2-carboxylic acids, 7-chloro-3-arylaminocarbonylmethyl-1,3,4,5-tetrahydrobenz[cd]indole-2-carboxylic acids, as a new class of potent NMDA-glycine antagonists is described. The synthetic route to the key intermediate 12a comprises a regioselective iodination of 4-chloro-2-nitrotoluene, modified Reissert indole synthesis, Jeffery's Heck-type reaction with allyl alcohol, Wittig-Horner-Emmons reaction, and iodination at the indole C-3 position. The key step in the route is an intramolecular cyclization of 12a to give the tricyclic indole structure. Two methods of cyclization, (1) an intramolecular radical cyclization of 12a and (2) a sequence of intramolecular Heck reaction of 12a followed by a 1,4-reduction, were performed. The resulting tricyclic indole diester 13a was selectively hydrolyzed to afford the desired tricyclic indole monocarboxylic acid 16 on a multihundred gram scale without any chromatographic purifications. Optical resolution of 16 to (-)-isomer 17 and (+)-isomer 18 was carried out, and the resulting isomers were derivatized, respectively. Evaluation of the optically active derivatives for affinity to the NMDA-glycine binding site using the radio ligand binding assay with [(3)H]-5,7-dichlorokynurenic acid revealed that the derivatives of (-)-isomer 17 were more potent than the others and that especially substituted anilide (-)-isomer 24 (K(i) = 0.8 nM) showed high affinity.


Subject(s)
Glycine Agents/chemical synthesis , Indoles/chemical synthesis , N-Methylaspartate/antagonists & inhibitors , Animals , Binding Sites , Carboxylic Acids , Glycine , Glycine Agents/metabolism , Heterocyclic Compounds, 3-Ring/chemical synthesis , Humans , Indoles/metabolism , N-Methylaspartate/metabolism , Radioligand Assay , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/metabolism , Stereoisomerism , Structure-Activity Relationship
14.
Mol Cell Neurosci ; 17(2): 354-63, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11178872

ABSTRACT

Inherited congenital myoclonus of Poll Hereford calves is an autosomal recessive disease characterized by hyperesthesia and myoclonic jerks of the skeletal musculature that occur both spontaneously and in response to sensory stimuli. Binding studies have previously shown that myoclonus is associated with specific loss of [(3)H]strychnine-binding sites from spinal cord and brain stem in affected calves. In order to identify the mutation responsible for myoclonus, we examined the candidate genes, glycine receptor alpha1 (Glra1) and beta (Glrb) subunits, in affected and normal cattle. A nonsense mutation was found at amino acid 24, located in exon 2 of the Glra1 gene in both cDNA and genomic sequences from affected but not control animals. Immunohistochemistry, with a monoclonal antibody to alpha and beta subunits of the glycine receptor, revealed a loss of cell surface immunoreactivity in myoclonic animals, suggesting a failure in the assembly of the receptor that could explain the characteristic phenotype of the disease.


Subject(s)
Codon, Nonsense , Myoclonus/genetics , Receptors, Glycine/genetics , Alleles , Amino Acid Sequence , Animals , Base Sequence , Binding Sites/genetics , Brain Chemistry , Cattle , Cloning, Molecular , DNA, Complementary , Genetic Testing , Glycine Agents/metabolism , Glycine Agents/pharmacology , Immunohistochemistry , Molecular Sequence Data , Phenotype , Polymorphism, Genetic , Receptors, Glycine/analysis , Receptors, Glycine/metabolism , Strychnine/metabolism , Strychnine/pharmacology
15.
Mol Reprod Dev ; 58(2): 205-15, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11139233

ABSTRACT

Recent reports have provided evidence for the presence of amino acid neurotransmitter receptor/chloride channels in human and porcine spermatozoa and their involvement in the acrosome reaction (AR). In this work we investigated whether a glycine receptor (GlyR) was present in golden hamster sperm, and whether it had a role in the hamster AR. The neuronal GlyR agonist glycine, stimulated in a dose-dependent manner, the AR of hamster spermatozoa previously capacitated for at least 3 hr. This stimulation was completely inhibited by 50 microM (+)-bicuculline and by concentrations of strychnine as low as 10-50 nM; both agents are antagonists of neuronal GlyR when used at the concentrations reported in this study. beta-Alanine, another agonist of the neuronal GlyR, also stimulated the AR. The AR-stimulatory effect of this compound was completely abolished by 50 nM strychnine. The inhibitory effect of strychnine on the glycine-induced hamster sperm AR was completely overcome by subsequent treatment with the calcium ionophore ionomycin, demonstrating that the strychnine effect was specific for GlyR. Additional binding studies with (3)[H]-strychnine, the typical radioligand used to detect GlyR in several cells, demonstrated for the first time the presence of specific binding sites for strychnine in the hamster spermatozoa. Interestingly, binding increased during in vitro capacitation, particularly in those sperm suspensions showing high percentages of AR. Taken together these results strongly suggest the presence of a GlyR in the hamster spermatozoa, with a role in the AR when activated.


Subject(s)
Acrosome Reaction/physiology , Receptors, Glycine/metabolism , Spermatozoa/physiology , Animals , Cricetinae , Glycine/metabolism , Glycine Agents/metabolism , Male , Mesocricetus , Spermatozoa/metabolism , Strychnine/metabolism , Taurine/metabolism , beta-Alanine/metabolism
16.
Drug Metabol Drug Interact ; 16(3): 173-89, 2000.
Article in English | MEDLINE | ID: mdl-11116752

ABSTRACT

The major metabolic pathway for elimination of GV150526 is by glucuronidation exerted by glucuronosyl transferases (UGTs). Potential exists for the modification of GV150526 pharmacokinetics by drugs capable of inhibiting the glucuronidation of GV150526. Using human liver microsomes, 44 compounds were screened for inhibition of GV150526 glucuronidation. These compounds were selected because they are extensively glucuronidated themselves or are used as concomitant medication in the treatment of acute stroke. For 11 compounds out of the 44, full inhibition kinetics were performed to determine their Ki-value and mechanism of inhibition. To predict possible in vivo drug-drug interactions, the theoretical percentage of inhibition (i) was determined, based on in vitro determined Ki-values, and the expected Cmax plasma levels of GV150526 and the inhibitor. Of the 11 compounds examined, only propofol had an i-value of 6.6; for all other compounds i-values were lower than 2.1. These results indicate that although in vitro inhibition is observed, the likelihood of in vivo drug-drug metabolic interactions occurring is low. The inhibition results suggest that in addition to UGT1A1, also UGT1A3, UGT1A8/9, and UGT2B4 are involved in the glucuronidation of GV150526. The involvement of UGT1A1 and UGT1A8/9 was confirmed from studies using cDNA expressed human UGT cell lines.


Subject(s)
Excitatory Amino Acid Antagonists/metabolism , Glucuronosyltransferase/physiology , Glycine Agents/metabolism , Indoles/metabolism , Microsomes, Liver/metabolism , DNA, Complementary/genetics , Dose-Response Relationship, Drug , Gene Expression , Glucuronic Acid/metabolism , Glucuronosyltransferase/genetics , Humans , Xenobiotics/pharmacology
17.
Br J Pharmacol ; 130(1): 65-72, 2000 May.
Article in English | MEDLINE | ID: mdl-10780999

ABSTRACT

The potency of two novel glycine site antagonists, GV150,526A and GV196,771A, was assessed by their ability to inhibit the binding of [(3)H]-MDL105,519 to cell homogenates prepared from mammalian cells transfected with either NR1-1a, NR1-2a, NR1-1a/NR2A, NR1-1a/NR2B, NR1-1a/NR2C or NR1-1a/NR2D NMDA receptor clones. The inhibition constants (K(i)s) for GV150,526A displacement of [(3)H]-MDL105,519 binding to either NR1-1a or NR1-2a expressed alone were not significantly different and were best fit by a one-site binding model. GV150,526A inhibition to NR1-1a/NR2 combinations was best fit by a two-site model with the NR1-1a/NR2C having an approximate 2 - 4 fold lower affinity compared to other NR1-1a/NR2 receptors. The K(i)s for GV196,771A displacement of [(3)H]-MDL105,519 binding to NR1-1a, NR1-2a and all NR1-1a/NR2 combinations was best fit by a two-site binding model. There was no significant difference between the K(i)s for the binding to NR1-1a and NR1-2a; NR1-1a/NR2A receptors had an approximate 4 fold lower affinity for GV196,771A compared to other NR1-1a/NR2 combinations. The K(i)s for both GV150, 526A and GV196,771A for the inhibition of [(3)H]-MDL105,519 binding to membranes prepared from adult rat forebrain were determined and compared to the values obtained for binding to cloned NMDA receptors. The K(i)s for a series of glycine site ligands with diverse chemical structures were also determined for the inhibition of [(3)H]-MDL105,519 binding to NR1-1a/NR2A receptors. L689,560 displayed similar binding characteristics to GV150,526A. It is suggested that glycine site antagonists may be divided into two classes based on their ability to distinguish between NR1 and NR1/NR2 receptors with respect to binding curve characteristics.


Subject(s)
Excitatory Amino Acid Antagonists/metabolism , Glycine Agents/metabolism , Indoles/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , Cells, Cultured , Excitatory Amino Acid Antagonists/pharmacology , Glycine Agents/chemistry , Glycine Agents/pharmacology , Indoles/pharmacology , Prosencephalon/metabolism , Pyrroles/metabolism , Pyrroles/pharmacology , Rats , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
18.
Eur J Pharmacol ; 391(3): 233-41, 2000 Mar 17.
Article in English | MEDLINE | ID: mdl-10729363

ABSTRACT

Binding of the glycine site antagonist 3-[2-(Phenylamino-carbonyl)ethenyl]-4,6-dichloro-indole-2-carboxylic acid sodium salt ([3H]GV150526A) was characterised in rat cerebral cortical membranes. Saturation experiments indicated the existence of a high affinity binding site, with a pK(d) value of 9.08 (K(d)=0. 8 nM) and a B(max) of 3.4 pmol/mg of protein. A strong linear correlation was observed between the displacement potencies for [3H]GV150526A and [3H]glycine of 13 glycine site ligands (r=0.991). The association kinetics of [3H]GV150526A binding was monophasic, with a k(on) value of 0.047 (nM)(-1) min(-1). Dissociation was induced by the addition of an excess of glycine, GV150526A, or 5,7-dichlorokynurenic acid (DCKA), another glycine antagonist. With GV150526A and DCKA, the dissociation curves presented similar k(off) values (0.068 and 0.069 min(-1), respectively), as expected from ligands binding to the same site. Conversely, a significantly lower k(off) value (0.027 min(-1)) was found with glycine. Although these data may suggest that glycine agonists and antagonists bind to discrete sites with an allosteric linkage (rather than interacting competitively), the reason for this difference remains to be elucidated. It is concluded that [3H]GV150526A can be considered a new valuable tool to further investigate the properties of the glycine site of the NMDA receptor.


Subject(s)
Cerebral Cortex/metabolism , Excitatory Amino Acid Antagonists/metabolism , Glycine Agents/metabolism , Indoles/metabolism , Receptors, Glycine/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Synaptic Membranes/metabolism , Animals , Binding, Competitive , Cerebral Cortex/ultrastructure , In Vitro Techniques , Kinetics , Male , Radioligand Assay , Rats , Rats, Sprague-Dawley , Receptors, Glycine/antagonists & inhibitors , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
19.
Farmaco ; 54(1-2): 101-11, 1999.
Article in English | MEDLINE | ID: mdl-10321036

ABSTRACT

Twenty 4,5-dimethylpyrrole-2-carboxylic acids (5a-t) with different 2-carbamoylvinyl chains in position 3 were prepared to further investigate the relationships between structure and in vitro affinity for the strychnine-insensitive glycine-binding site. None of these compounds was superior to (E)-3-(N-phenyl-2-carbamoylvinyl)-4,5-dimethylpyrrole-2-carb oxylic acid III (pKi = 6.70), which was taken as a reference standard, but overall the results obtained indicate that the N-phenyl-2-carbamoylvinyl substituent of III may be replaced with the N-(1-adamantyl)-2-carbamoylvinyl group as in 5h (pKi = 6.20) without considerable loss of affinity. This finding adds to previous knowledge.


Subject(s)
Carboxylic Acids/chemical synthesis , Glycine Agents/chemical synthesis , Pyrroles/chemical synthesis , Receptors, N-Methyl-D-Aspartate/drug effects , Animals , Carboxylic Acids/chemistry , Carboxylic Acids/metabolism , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/ultrastructure , Glycine Agents/chemistry , Glycine Agents/metabolism , In Vitro Techniques , Ligands , Pyrroles/chemistry , Pyrroles/metabolism , Rats , Receptors, N-Methyl-D-Aspartate/metabolism , Structure-Activity Relationship , Strychnine/pharmacology , Synaptosomes/drug effects , Synaptosomes/metabolism
20.
Biol Psychiatry ; 45(6): 668-79, 1999 Mar 15.
Article in English | MEDLINE | ID: mdl-10187996

ABSTRACT

BACKGROUND: Phencycline (PCP, "angel dust") and other noncompetitive antagonists of N-methyl-D-aspartate (NMDA)-type glutamatergic neurotransmission induce psychotic effects in humans that closely resemble positive, negative, and cognitive symptoms of schizophrenia. Behavioral effects of PCP in rodents are reversed by glycine (GLY) and other NMDA augmenting agents. In rodents, behavioral effects of PCP are mediated, in part, by secondary dysregulation of subcortical dopaminergic neurotransmission. This study evaluates effects of GLY and GLY transport antagonists on behavioral and neurochemical consequences of PCP administration in rodents. METHODS: Two separate experiments were performed. In the first, effects of GLY on PCP-induced stimulation of dopaminergic neurotransmission in nucleus accumbens were evaluated using in vivo microdialysis in awake animals. In the second, effects of a series of GLY transport antagonists were evaluated for potency in inhibiting PCP-induced hyperactivity. RESULTS: In microdialysis studies, GLY significantly inhibited PCP-induced stimulation of subcortical DA release in a dose-dependent fashion. In behavioral studies, the potency of a series of GLY transport antagonists for inhibiting PCP-induced hyperactivity in vivo correlated significantly with their potency in antagonizing GLY transport in vitro. CONCLUSIONS: These findings suggest, first, that GLY reverses not only the behavioral, but also the neurochemical, effects of PCP in rodents. Second, the findings suggest that GLY transport antagonists may induce similar effects to GLY, and may therefore represent an appropriate site for targeted drug development.


Subject(s)
Dopamine/metabolism , Glycine Agents/metabolism , Glycine Agents/pharmacokinetics , Hallucinogens/metabolism , Hallucinogens/pharmacokinetics , N-Methylaspartate/metabolism , Neurotransmitter Uptake Inhibitors/pharmacology , Phencyclidine/metabolism , Phencyclidine/pharmacokinetics , Schizophrenia/metabolism , Animals , Awards and Prizes , Brain/metabolism , Male , Microdialysis , Psychiatry , Rats , Rats, Sprague-Dawley , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...